Staging of Breast Cancer with Ultrasound

Seminars in Ultrasound, CT and MRI

Volumn 32, Issue 4, 2011, Pages 331-341

  Yang, Wei Tse ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER INVASION; CANCER LOCALIZATION; CANCER MORPHOLOGY; CANCER RADIOTHERAPY; CANCER STAGING; CLIP; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOMAMMOGRAPHY; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; INTRADUCTAL CARCINOMA; INTRAOPERATIVE PERIOD; INVASIVE LOBULAR CANCER; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAMMOGRAPHY; MICROBUBBLE; MULTIPLE CANCER; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOSENSITIVITY; TREATMENT PLANNING; TREATMENT RESPONSE; TUMOR VOLUME;

BIOPSY, NEEDLE; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; NEOPLASM STAGING; ULTRASONOGRAPHY, MAMMARY;

EID: 79960474683     PISSN: 08872171     EISSN: 15585034     Source Type: Journal    
DOI: 10.1053/j.sult.2011.02.008     Document Type: Article

References (54)

1. Fisher B. Sounding board. Breast-cancer management: Alternatives to radical mastectomy. N Engl J Med 1979, 301:326-328.
2. Holland R., Veling S.H., Mravunac M., et al. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 1985, 56:979-990.
3. Lagios M.D., Westdahl P.R., Rose M.R. The concept and implications of multicentricity in breast carcinoma. Pathol Annu 1981, 16:83-102.
4. Berg W.A., Gilbreath P.L. Multicentric and multifocal cancer: Whole-breast US in preoperative evaluation. Radiology 2000, 214:59-66.
5. Stavros A.T. Malignant solid breast nodules: Specific types. Breast Ultrasound 2004, 597-688. Lippincott Williams & Wilkins, Philadelphia, PA. A.T. Stavros (Ed.).
6. Moon W.K., Noh D.Y., Im J.G. Multifocal, multicentric, and contralateral breast cancers: Bilateral whole-breast US in the preoperative evaluation of patients. Radiology 2002, 224:569-576.
7. Berg W.A., Gutierrez L., NessAiver M.S., et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 2004, 233:830-849.
8. Kim M.J., Kim E.K., Kwak J.Y., et al. Bilateral synchronous breast cancer in an Asian population: Mammographic and sonographic characteristics, detection methods, and staging. AJR Am J Roentgenol 2008, 190:208-213.
9. Heron D.E., Komarnicky L.T., Hyslop T., et al. Bilateral breast carcinoma: Risk factors and outcomes for patients with synchronous and metachronous disease. Cancer 2000, 88:2739-2750.
10. Tavassoli F.A., Devilee P. Invasive Lobular Carcinoma. World Health Organization Classification of Tumours Pathology and Genetics of Tumours of the Breast and Female Genital Organs 2003, 23-26. International Agency for Research on Cancer, Lyon, France. F.A. Tavassoli, P. Devilee (Eds.).
11. Harvey J.A., Fechner R.E., Moore M.M. Apparent ipsilateral decrease in breast size at mammography: A sign of infiltrating lobular carcinoma. Radiology 2000, 214:883-889.
12. Le Gal M., Ollivier L., Asselain B., et al. Mammographic features of 455 invasive lobular carcinomas. Radiology 1992, 185:705-708.
13. Butler R.S., Venta L.A., Wiley E.L., et al. Sonographic evaluation of infiltrating lobular carcinoma. AJR Am J Roentgenol 1999, 172:325-330.
14. Rissanen T., Tikkakoski T., Autio A.L., et al. Ultrasonography of invasive lobular breast carcinoma. Acta Radiol 1998, 39:285-291.
15. Skaane P., Skjorten F. Ultrasonographic evaluation of invasive lobular carcinoma. Acta Radiol 1999, 40:369-375.
16. Paramagul C.P., Helvie M.A., Adler D.D. Invasive lobular carcinoma: Sonographic appearance and role of sonography in improving diagnostic sensitivity. Radiology 1995, 195:231-234.
17. Selinko V.L., Middleton L.P., Dempsey P.J. Role of sonography in diagnosing and staging invasive lobular carcinoma. J Clin Ultrasound 2004, 32:323-332.
18. Weinstein S.P., Orel S.G., Heller R., et al. MR imaging of the breast in patients with invasive lobular carcinoma. AJR Am J Roentgenol 2001, 176:399-406.
19. Mann R.M., Veltman J., Barentsz J.O., et al. The value of MRI compared to mammography in the assessment of tumour extent in invasive lobular carcinoma of the breast. Eur J Surg Oncol 2008, 34:135-142.
20. Yang W.T., Tse G.M. Sonographic, mammographic, and histopathologic correlation of symptomatic ductal carcinoma in situ. AJR Am J Roentgenol 2004, 182:101-110.
21. Ikeda D.M., Andersson I. Ductal carcinoma in situ: Atypical mammographic appearances. Radiology 1989, 172:661-666.
22. Cho N., Moon W.K., Chang J.M., et al. Ultrasonography-guided vacuum-assisted biopsy of microcalcifications: Comparison of the diagnostic yield of calcified cores and non-calcified cores on specimen radiographs. Acta Radiol 2010, 51:123-127.
23. Khan A., Sabel M.S., Nees A., et al. Comprehensive axillary evaluation in neoadjuvant chemotherapy patients with ultrasonography and sentinel lymph node biopsy. Ann Surg Oncol 2005, 12:697-704.
24. Kilbride K.E., Lee M.C., Nees A.V., et al. Axillary staging prior to neoadjuvant chemotherapy for breast cancer: Predictors of recurrence. Ann Surg Oncol 2008, 15:3252-3258.
25. Zhang Y.J., Oh J.L., Whitman G.J., et al. Clinically apparent internal mammary nodal metastasis in patients with advanced breast cancer: Incidence and local control. Int J Radiat Oncol Biol Phys 2010, 77:1113-1119.
26. Ahn J.H., Son E.J., Kim J.A., et al. The role of ultrasonography and FDG-PET in axillary lymph node staging of breast cancer. Acta Radiol 2010, 51:859-865.
27. Shen J., Hunt K.K., Mirza N.Q., et al. Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma. Cancer 2004, 101:1330-1337.
28. Yang W.T., Ahuja A., Tang A., et al. Ultrasonographic demonstration of normal axillary lymph nodes: A learning curve. J Ultrasound Med 1995, 14:823-827.
29. Bedi D.G., Krishnamurthy R., Krishnamurthy S., et al. Cortical morphologic features of axillary lymph nodes as a predictor of metastasis in breast cancer: In vitro sonographic study. AJR Am J Roentgenol 2008, 191:646-652.
30. Alvarez S., Anorbe E., Alcorta P., et al. Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: A systematic review. AJR Am J Roentgenol 2006, 186:1342-1348.
31. Yang W.T., Ahuja A., Tang A., et al. High resolution sonographic detection of axillary lymph node metastases in breast cancer. J Ultrasound Med 1996, 15:241-246.
32. Yang W.T., Chang J., Metreweli C. Patients with breast cancer: Differences in color Doppler flow and gray-scale US features of benign and malignant axillary lymph nodes. Radiology 2000, 215:568-573.
33. Mainiero M.B. Regional lymph node staging in breast cancer: The increasing role of imaging and ultrasound-guided axillary lymph node fine needle aspiration. Radiol Clin North Am 2010, 48:989-997.
34. Baruah B.P., Goyal A., Young P., et al. Axillary node staging by ultrasonography and fine-needle aspiration cytology in patients with breast cancer. Br J Surg 2010, 97:680-683.
35. Krishnamurthy S., Sneige N., Bedi D.G., et al. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Cancer 2002, 95:982-988.
36. Davis J.T., Brill Y.M., Simmons S., et al. Ultrasound-guided fine-needle aspiration of clinically negative lymph nodes versus sentinel node mapping in patients at high risk for axillary metastasis. Ann Surg Oncol 2006, 13:1545-1552.
37. Greene F.L., Page D.L., Fleming I.D., et al. Cancer Staging Manual 2002, 221-240. American joint cancer Committee, Springer-Verlag, New York. (ed 6).
38. Kuerer H.M., Newman L.A., Buzdar A.U., et al. Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer. Am J Surg 1998, 176:502-509.
39. Krishnamurthy S. Current applications and future prospects of fine-needle aspiration biopsy of locoregional lymph nodes in the management of breast cancer. Cancer Cytopathol 2009, 117:451-462.
40. Garcia-Ortega M.J., Benito M.A., Vahamonde E.F., et al. Pretreatment axillary ultrasonography and core biopsy in patients with suspected breast cancer: Diagnostic accuracy and impact on management. Eur J Radiol 2010 January 2, (Epub ahead of print).
41. Abe H., Schmidt R.A., Kulkarni K., et al. Axillary lymph nodes suspicious for breast cancer metastasis: sampling with US-guided 14-gauge core-needle biopsy-clinical experience in 100 patients. Radiology 2009, 250:41-49.
42. Damera A., Evans A.J., Cornford E.J., et al. Diagnosis of axillary nodal metastases by ultrasound-guided core biopsy in primary operable breast cancer. Br J Cancer 2003, 89:1310-1313.
43. Britton P.D., Goud A., Godward S., et al. Use of ultrasound-guided axillary node core biopsy in staging of early breast cancer. Eur Radiol 2009, 19:561-569.
44. Rao R., Lilley L., Andrews V., et al. Axillary staging by percutaneous biopsy: Sensitivity of fine-needle aspiration versus core needle biopsy. Ann Surg Oncol 2009, 16:1170-1175.
45. Phillips S.W., Gabriel H., Comstock C.E., et al. Sonographically guided metallic clip placement after core needle biopsy of the breast. AJR Am J Roentgenol 2000, 175:1353-1355.
46. Oh J.L., Nguyen G., Whitman G.J., et al. Placement of radio-opaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy. Cancer 2007, 110:2420-2427.
47. Keune J.D., Jeffe D.B., Schootman M., et al. Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer. Am J Surg 2010, 199:477-484.
48. Chagpar A.B., Middleton L.P., Sahin A.A., et al. Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy. Ann Surg 2006, 243:257-264.
49. Peintinger F., Kuerer H.M., Anderson K., et al. Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy. Ann Surg Oncol 2006, 13:1443-1449.
50. Herrada J., Iyer R.B., Atkinson E.N., et al. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma. Clin Cancer Res 1997, 3:1565-1569.
51. Schott A.F., Roubidoux M.A., Helvie M.A., et al. Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy. Breast Cancer Res Treat 2005, 92:231-238.
52. Cheung Y.C., Chen S.C., Su M.Y., et al. Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI. Breast Cancer Res Treat 2003, 78:51-58.
53. Bennett I.C., Greenslade J., Chiam H. Intraoperative ultrasound-guided excision of nonpalpable breast lesions. World J Surg 2005, 29:369-374.
54. Paramo J.C., Landeros M., McPhee M.D., et al. Intraoperative ultrasound-Guided excision of nonpalpable Breast Lesions. Breast J 1999, 5:389-394.